Roy J. Wu
Keine laufenden Positionen mehr
Profil
Mr. Roy J.
Wu was Senior VP-Business & Corporate Development at NovaBay Pharmaceuticals, Inc.
Mr. Wu was previously employed as Vice President-Business Development by Genelabs Technologies, Inc., Secretary & Vice President by Kissei Pharma USA, Inc., a Director-Business Development by Quintiles, and a Director-Research & Development by Syntex Corp.
He received his undergraduate degree from the University of San Francisco and an MBA from the University of San Francisco.
Ehemalige bekannte Positionen von Roy J. Wu
| Unternehmen | Position | Ende |
|---|---|---|
| NOVABAY PHARMACEUTICALS | Corporate Officer/Principal | 29.02.2016 |
Genelabs Technologies, Inc.
 Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Corporate Officer/Principal | 01.01.2009 |
| Kissei Pharma USA, Inc. | Unternehmenssekretär | 01.10.2001 |
| Quintiles/BRI | Corporate Officer/Principal | 01.01.1997 |
| Syntex Corp. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Roy J. Wu
| University of San Francisco | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NOVABAY PHARMACEUTICALS | Health Technology |
| Private Unternehmen | 4 |
|---|---|
| Syntex Corp. | Health Technology |
Genelabs Technologies, Inc.
Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Health Technology |
| Quintiles/BRI | |
| Kissei Pharma USA, Inc. |
